文献速递耳科与耳神经小儿耳鼻咽喉

基于6年纵向数据收集的先天性巨细胞病毒 vestibular 随访方案

Vestibular Follow-up Program for Congenital Cytomegalovirus Based on 6 Years of Longitudinal Data Collection.
PubMed 文献 · Ear Hear · 2023-05-01

这项纵向队列研究纳入185例先天性巨细胞病毒(cCMV)患者,平均年龄3.2岁,通过视频头脉冲试验和颈性/眼性前庭诱发肌源性电位进行前庭随访。16.8%(31/185)患者在随访期间出现前庭丧失,6%(10/164)初次评估正常者出现迟发性前庭丧失,其中80.0%(8/10)发生在2岁内。作者建议对具有前庭危险因素(早孕期或未知时机血清转换、感音神经性听力损失、MRI脑室周围囊肿)的cCMV患者进行纵向前庭随访,尤其在生后2年内最密集;若可排除这些危险因素,生后早期(约6月龄)单次评估可能足够。

要点

  • cCMV患者随访期间前庭丧失发生率为16.8%(31/185)。
  • 初次前庭功能正常者中6%(10/164)出现迟发性前庭丧失,80.0%(8/10)在2岁内。
  • 有前庭危险因素者建议纵向随访,无危险因素者约6月龄单次评估可能足够。

核心结论

  • 建议对具有前庭危险因素(早孕期或未知时机血清转换;感音神经性听力损失;MRI脑室周围囊肿)的cCMV患者进行纵向前庭随访,生后2年内最密集。
  • 若可排除上述危险因素,生后早期(约6月龄)单次评估可能足够。
  • 随访方案应包括半规管和耳石器系统评估,因为部分性前庭丧失已有报告。

研究设计与样本

  • 纵向队列研究,纳入185例cCMV患者,平均年龄3.2岁(SD 1.6岁,范围0.5-6.7岁)。
  • 通过水平视频头脉冲试验(vHIT)和颈性前庭诱发肌源性电位(cVEMP)在约6月龄、1岁和2岁时评估;约3岁和4.5岁时收集垂直vHIT和眼性前庭诱发肌源性电位(oVEMP)数据。

主要发现

  • 出生时55.1%(102/185)无症状,44.9%(83/185)有症状。
  • 所有患者平均随访20.8个月(SD 16.3),平均随访评估次数3.2次(SD 1.5)。
  • 随访期间16.8%(31/185)患者出现前庭丧失;初次评估前庭功能正常的患者中6%(10/164)出现迟发性前庭丧失,其中80.0%(8/10)发生在生后2年内。
  • 最终评估时,前庭受损耳中多数(29/36,80.6%)半规管和耳石器系统均受损;仅半规管系统或仅耳石器系统功能障碍分别占4耳(4/36,11.1%)和3耳(3/36,8.3%)。
  • 前庭丧失发生率最高见于早孕期血清转换者(16/59,27.1%)、血清转换时机未知者(13/71,18.3%)、感音神经性听力损失者(16/31,51.6%)和MRI显示脑室周围囊肿者(7/11,63.6%)。

临床怎么用

  • 作者建议对具有前庭危险因素(早孕期或未知时机血清转换;感音神经性听力损失;MRI脑室周围囊肿)的cCMV患者进行纵向前庭随访,生后2年内最密集。
  • 作者认为若可排除上述危险因素,生后早期(约6月龄)单次评估可能足够。
  • 作者建议随访方案应包括半规管和耳石器系统评估,因为部分性前庭丧失已有报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Congenital cytomegalovirus (cCMV), the leading nongenetic cause of pediatric sensorineural hearing loss, can also affect vestibular function. Literature findings suggest clinical presentation of vestibular loss in cCMV to be as variable as the hearing loss. Still, probably due to the considerable additional burden it entails for both patients and diagnostic centers, longitudinal vestibular follow-up in cCMV is not well-established in clinical practice. Therefore, this study aims to propose an evidence-based vestibular follow-up program with proper balance between its feasibility and sensitivity. DESIGN: In this longitudinal cohort study, 185 cCMV-patients (mean age 3.2 years, SD 1.6 years, range 0.5-6.7 years) were included. Vestibular follow-up data were obtained through lateral video head impulse test (vHIT) and cervical vestibular evoked myogenic potential (cVEMP) evaluations around the ages of 6 months, 1 year, and 2 years. Around 3 and 4.5 years of age, data from vertical vHIT and ocular vestibular evoked myogenic potentials (oVEMP) were also collected. RESULTS: At birth, 55.1% (102/185) of patients were asymptomatic and 44.9% (83/185) were symptomatic. The mean duration of follow-up for all patients was 20.8 (SD 16.3) months (mean number of follow-up assessments: 3.2, SD 1.5). Vestibular loss occurred at some point during follow-up in 16.8% (31/185) of all patients. Six percent (10/164) of patients with normal vestibular function at first assessment developed delayed-onset vestibular loss; 80.0% (8/10) of these within the first 2 years of life. Vestibular deterioration was reported both in patients who had been treated with postnatal antiviral therapy and untreated patients. At final evaluation, both the semicircular and the otolith system were impaired in the majority of vestibular-impaired ears (29/36, 80.6%). Dysfunctions limited to the semicircular system or the otolith system were reported in 4 (4/36, 11.1%) and 3 (3/36, 8.3%) ears, respectively. The occurrence of vestibular loss was highest in patients with first trimester seroconversion (16/59, 27.1%) or with an unknown timing of seroconversion (13/71, 18.3%), patients with sensorineural hearing loss (16/31, 51.6%), and patients with periventricular cysts on magnetic resonance imaging (MRI) (7/11, 63.6%). CONCLUSIONS: Longitudinal vestibular follow-up, most intensively during the first 2 years of life, is recommended in cCMV-patients with vestibular risk factors (first trimester or unknown timing of seroconversion; sensorineural hearing loss; periventricular cysts on MRI). If those risk factors can be ruled out, a single evaluation early in life (around 6 months of age) might be sufficient. Both semicircular and otolith system evaluation should be part of the follow-up program, as partial losses were reported.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Dhondt C, Maes L, Van Acker E, et al. Vestibular Follow-up Program for Congenital Cytomegalovirus Based on 6 Years of Longitudinal Data Collection. Ear Hear. 2023. PMID: 37122081. doi:10.1097/AUD.0000000000001377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。